Skip to main content
Log in

Aneurysmascreening in Risikogruppen: Sinnvoll?

Screening for aneurysms in risk groups: meaningful?

  • Subarachnoidalblutung
  • Published:
Der Radiologe Aims and scope Submit manuscript

Zusammenfassung

Aneurysmascreening in Risikogruppen wird kontrovers diskutiert. Eindeutige Empfehlungen existieren z. Z. nicht. Ein Screening bei Patienten mit familiären Aneurysmen erscheint nicht empfehlenswert. Patienten mit einer polyzystischen Nierendegeneration (ADPKD) und bereits familiären SAB-Fällen sollten jedoch bei einer Prävalenz von 25% intrakranieller Aneurysmen alle 2–3 Jahre mittels MRT-Angiographie untersucht werden.

Abstract

There is a controversy discussion on screening for aneurysms in risk groups. True guidelines do not exist so far. It seems that screening for familial aneurysms is not advisable today. But adult dominant polycystic kidney disease (ADPKD) patients with a familial history of SAH should be screened because of a high prevalence rate of 25% for intracranial aneurysms in this population. Screening should be performed every 2 to 3 years by MRI angiography in this special risk group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

Dr. med. Tobias Struffert Klinik für bildgebende Diagnostik und Interventionen, Klinikum Saarbrücken, Winterberg 1, 66119 Saarbrücken, E-Mail: t.struffert@worldonline.de

Rights and permissions

Reprints and permissions

About this article

Cite this article

Struffert, T., Reith, W. Aneurysmascreening in Risikogruppen: Sinnvoll?. Radiologe 42, 880–884 (2002). https://doi.org/10.1007/s00117-002-0818-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-002-0818-y

Navigation